Asclepius Life Sciences Fund, LP
Venture capitalNew York · Seed–Series B · 4 people tracked
Investment thesis
Asclepius invests exclusively in private-market life sciences companies, spanning healthcare, pharmaceuticals, agriculture, personal care, biosciences and biotechnology. The fund seeks to exploit market inefficiencies by combining operational expertise, deep scientific insight and rigorous financial analysis, drawing on a leadership team with extensive experience across investment, biopharmaceuticals, life sciences and healthcare management.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's website & public directoriesFrequently asked questions
- What stage does Asclepius Life Sciences Fund, LP invest at?
- Asclepius Life Sciences Fund, LP invests at the Seed, Series A, Series B stages.
- What sectors does Asclepius Life Sciences Fund, LP focus on?
- Asclepius Life Sciences Fund, LP focuses on AgTech, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Asclepius Life Sciences Fund, LP located?
- Asclepius Life Sciences Fund, LP is headquartered in New York, US.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.
BioGenerator Ventures creates, builds, and invests in life sciences companies working on problems in human health and agriculture, pairing capital with company-building resources through BioGenerator Labs.

